Document:

Exhibit 10.1

 

STANDBY EQUITY PURCHASE AGREEMENT

 

THIS STANDBY EQUITY PURCHASE
AGREEMENT (this “Agreement”) dated as of August 31, 2022 is made by and between YA II PN, LTD., a Cayman
Islands exempt limited partnership (the “Investor”), and RUBICON TECHNOLOGIES, INC. (formerly Founder SPAC),
a Delaware corporation (the “Company”).

 

WHEREAS, on August
15, 2022, the Company consummated the Business Combination described in that Proxy Statement for Extraordinary General Meeting of the
Company filed on July 6, 2022 with the U.S. Securities and Exchange Commission;

 

WHEREAS, the parties
desire that, upon the terms and subject to the conditions contained herein, the Company shall have the right to issue and sell to the
Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up $200.0 million of the Company’s
shares of Class A common stock, par value $0.0001 per share (the “Common Shares”); and

 

WHEREAS, the Common
Shares are listed for trading on the New York Stock Exchange under the symbol “RBT;” and

 

WHEREAS, the offer
and sale of the Common Shares issuable hereunder will be made in reliance upon Section 4(a)(2) under the Securities Act of 1933, as amended,
and the rules and regulations promulgated thereunder (the “Securities Act”), or upon such other exemption from the
registration requirements of the Securities Act as may be available with respect to any or all of the transactions to be made hereunder.

 

NOW, THEREFORE,
the parties hereto agree as follows:

 

Article I. Certain Definitions

 

“Additional Shares”
shall have the meaning set forth in ‎Section 2.01(d)(ii).

 

“Adjusted Advance
Amount” shall have the meaning set forth in ‎Section 2.01(d)(i).

 

“Advance”
shall mean any issuance and sale of Advance Shares from the Company to the Investor pursuant to ‎Article II hereof.

 

“Advance Date”
shall mean the 1st Trading Day after expiration of the applicable Pricing Period for each Advance.

 

“Advance Notice”
shall mean a written notice in the form of Exhibit A attached hereto to the Investor executed by an officer of the Company and setting
forth the dollar amount of an Advance that the Company desires to issue and sell to the Investor.

 

“Advance Notice Date”
shall mean each date the Company is deemed to have delivered (in accordance with ‎Section 2.01(b) of this Agreement) an Advance Notice
to the Investor, subject to the terms of this Agreement.

 

     

     

    

 

“Advance Shares”
shall mean the Common Shares that the Company shall issue and sell to the Investor.

 

“Affiliate”
shall have the meaning set forth in ‎Section 3.07.

 

“Agreement”
shall have the meaning set forth in the preamble of this Agreement.

 

“Applicable Laws”
shall mean all applicable laws, statutes, rules, regulations, orders, executive orders, directives, policies, guidelines and codes having
the force of law, whether local, national, or international, as amended from time to time, including without limitation (i) all applicable
laws that relate to money laundering, terrorist financing, financial record keeping and reporting, (ii) all applicable laws that relate
to anti-bribery, anti-corruption, books and records and internal controls, including the United States Foreign Corrupt Practices Act of
1977, and (iii) any Sanctions laws.

 

“Black Out Period”
shall have the meaning set forth in ‎Section 6.01(e)

 

“Closing”
shall have the meaning set forth in Section 2.02.

 

“Commitment Amount”
shall mean $200,000,000 of Common Shares, provided that, the Company shall not affect any sales under this Agreement and the Investor
shall not have the obligation to purchase Common Shares under this Agreement to the extent (but only to the extent) that after giving
effect to such purchase and sale the aggregate number of Common Shares issued under this Agreement together with any Common Stock issued
in connection with any other related transactions that may be considered part of the same series of transactions, would exceed 19.9% of
the outstanding Voting Common Stock as of the date of this Agreement (the “Exchange Cap”) provided further that,
the Exchange Cap will not apply if (a) the Company’s stockholders have approved issuances in excess of the Exchange Cap in accordance
with the rules of the Principal Market or (b) the Company concludes, after consultation with outside counsel to the Company that such
approval is not required, which conclusion shall be reasonably satisfactory to the Investor.

 

“Commitment Fee Shares”
shall have the meaning set forth in ‎Section 12.04

 

“Commitment Period”
shall mean the period commencing on the date hereof and expiring upon the date of termination of this Agreement in accordance with Section
10.01.

 

“Common Shares”
shall have the meaning set forth in the recitals of this Agreement.

 

“Company”
shall have the meaning set forth in the preamble of this Agreement.

 

“Company Indemnitees”
shall have the meaning set forth in ‎Section 5.02.

 

“Condition Satisfaction
Date” shall have the meaning set forth in ‎Section 7.01.

 

“Daily Traded Value”
shall mean the product obtained by multiplying the daily trading volume of the Company’s Common Shares on the Principal Market during
regular trading hours as reported by Bloomberg L.P., by the VWAP for such Trading Day.

 

    2 

     

    

 

“Environmental Laws”
shall have the meaning set forth in ‎Section 4.13.

 

“Exchange Act”
shall mean the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Excluded Day”
shall have the meaning set forth in ‎Section 2.01(d)(i).

 

“Hazardous Materials”
shall have the meaning set forth in ‎Section 4.13.

 

“Indemnified Liabilities”
shall have the meaning set forth in ‎Section 5.01.

 

“Investor”
shall have the meaning set forth in the preamble of this Agreement.

 

“Investor Indemnitees”
shall have the meaning set forth in ‎Section 5.01.

 

“Market Price”
shall mean the lowest daily VWAP of the Common Shares during the relevant Pricing Period, other than the daily VWAP on any Excluded Days.

 

“Material Adverse
Effect” shall mean any event, occurrence or condition that has had or would reasonably be expected to have (i) a material adverse
effect on the legality, validity or enforceability of this Agreement or the transactions contemplated herein, (ii) a material adverse
effect on the results of operations, assets, business or condition (financial or otherwise) of the Company and its Subsidiaries, taken
as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its
obligations under this Agreement.

 

“Material Outside
Event” shall have the meaning set forth in ‎Section 6.08.

 

“Maximum Advance
Amount” in respect of each Advance Notice means the greater of: (i) an amount equal to the average Daily Traded Value of Common
Shares on the Company’s Principal Market on the five (5) Trading Days immediately preceding an Advance Notice, or (ii) $10,000,000.

 

“Minimum Acceptable
Price” or “MAP” shall mean the minimum price notified by the Company to the Investor in each Advance Notice,
if applicable.

 

“OFAC”
shall have the meaning set forth in ‎Section 4.30.

 

“Ownership Limitation”
shall have the meaning set forth in ‎Section 2.01(c)(i).

 

“Person”
shall mean an individual, a corporation, a partnership, a limited liability company, a trust or other entity or organization, including
a government or political subdivision or an agency or instrumentality thereof.

 

“Plan of Distribution”
shall mean the section of a Registration Statement disclosing the plan of distribution of the Shares.

 

“Pricing Period”
shall mean the three (3) consecutive Trading Days commencing on the Advance Notice Date.

 

    3 

     

    

 

“Principal Market”
shall mean the New York Stock Exchange; provided however, that in the event the Company’s Common Shares are ever listed or traded
on the Nasdaq Global Market, the NYSE American, the Nasdaq Global Select Market, or the Nasdaq Capital Market, then the “Principal
Market” shall mean such other market or exchange on which the Company’s Common Shares are then listed or traded to the extent
such other market or exchange is the principal trading market or exchange for the Common Shares.

 

“Prospectus”
shall mean any prospectus (including, without limitation, all amendments and supplements thereto) used by the Company in connection with
a Registration Statement.

 

“Prospectus Supplement”
shall mean any prospectus supplement to a Prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act, including, without
limitation, any prospectus supplement to be filed in accordance with Section 6.01‎0 hereof.

 

“Purchase Price”
shall mean the price per Advance Share obtained by multiplying the Market Price by 97%.

 

“Registrable Securities”
shall mean (i) the Shares, and (ii) any securities issued or issuable with respect to any of the foregoing by way of exchange, stock dividend
or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise.

 

“Registration Limitation”
shall have the meaning set forth in ‎Section 2.01(c)(ii).

 

“Registration Statement”
shall mean a registration statement on Form S-1 or Form S-3 or on such other form promulgated by the SEC for which the Company then qualifies
and which counsel for the Company shall deem appropriate, and which form shall be available for the registration of the resale by the
Investor of the Registrable Securities under the Securities Act, which registration statement provides for the resale from time to time
of the Shares as provided herein.

 

“Regulation D”
shall mean the provisions of Regulation D promulgated under the Securities Act.

 

“Sanctions”
shall have the meaning set forth in ‎Section 4.30.

 

“Sanctioned Countries”
shall have the meaning set forth in ‎Section 4.30.

 

“SEC” shall
mean the U.S. Securities and Exchange Commission.

 

“SEC Documents”
shall have the meaning set forth in ‎Section 4.05.

 

“Securities Act”
shall have the meaning set forth in the recitals of this Agreement.

 

“Settlement Document”
shall have the meaning set forth in ‎Section 2.02(a).

 

“Shares”
shall mean the Commitment Shares and the Common Shares to be issued from time to time hereunder pursuant to an Advance.

 

    4 

     

    

 

“Subsidiaries”
shall mean any Person in which the Company, directly or indirectly, (x) owns a majority of the outstanding capital stock or holds a majority
of the equity or similar interest of such Person or (y) controls or operates all or substantially all of the business, operations or administration
of such Person, and the foregoing are collectively referred to herein as “Subsidiaries.”

 

“Trading Day”
shall mean any day during which the Principal Market shall be open for business.

 

“Transaction Documents”
shall have the meaning set forth in ‎Section 4.02.

 

“Voting Common Stock”
means the Common Shares and the Company’s shares of Class V common stock, par value $0.0001 per share.

 

“VWAP”
shall mean for any Trading Day, the daily volume weighted average price of the Common Shares for such Trading Day on the Principal Market
during regular trading hours as reported by Bloomberg L.P.

 

Article II. Advances

 

Section 2.01Advances;
Mechanics. Upon the terms and subject to the conditions of this Agreement, during the Commitment Period, the Company, at its sole
discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and the Investor shall purchase from the
Company, Advance Shares by the delivery to the Investor of Advance Notices on the following terms:

 

		(a)	Advance Notice. At any time during the Commitment Period the Company may require the Investor to
purchase Shares by delivering an Advance Notice to the Investor, subject to the satisfaction or waiver by the Investor of the conditions
set forth in Section 7.01, and in accordance with the following provisions:

 

		(i)	The Company shall, in its sole discretion, select the amount of the Advance, not to exceed the Maximum
Advance Amount, it desires to issue and sell to the Investor in each Advance Notice and the time it desires to deliver each Advance Notice.

 

		(ii)	There shall be no mandatory minimum Advances and no non-usages fee for not utilizing the Commitment Amount
or any part thereof.

 

		(b)	Date of Delivery of Advance Notice. Advance Notices shall be delivered in accordance with the instructions
set forth on the bottom of Exhibit A. An Advance Notice shall be deemed delivered on (i) the day it is received by the Investor
if such notice is received by email prior on or before 8:30 a.m. Eastern Time (or later if waived by the Investor in its sole discretion),
or (ii) the immediately succeeding day if it is received by email after 8:30 a.m. Eastern Time, in each case in accordance with the instructions
set forth on the bottom of Exhibit A.

 

    5 

     

    

 

		(c)	Advance Limitations. Regardless of the amount of an Advance requested by the Company in the Advance
Notice, the final number of Shares to be issued and sold pursuant to an Advance Notice shall be reduced (if at all) in accordance with
each of the following limitations:

 

		(i)	Ownership Limitation; Commitment Amount. Notwithstanding anything to the contrary contained in
this Agreement, the Investor shall not be obligated to purchase or acquire, and shall not purchase or acquire, any Common Shares under
this Agreement to the extent that after giving effect to such receipt of Common Shares would, when aggregated with all other Common Shares
beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated
thereunder), result in the beneficial ownership by the Investor and its affiliates (on an aggregated basis) to exceed 9.99% of the outstanding
number of Common Shares (the “Ownership Limitation”). Upon the written request of the Investor, the Company shall promptly
(but no later than the next business day on which the transfer agent for the Common Shares is open for business) confirm orally or in
writing to the Investor the number of Common Shares then outstanding. In connection with each Advance Notice delivered by the Company,
any portion of the Advance that would (i) cause the Investor to exceed the Ownership Limitation or (ii) result in the aggregate Purchase
Price of Shares issued and sold to the Investor hereunder to exceed the Commitment Amount shall automatically be withdrawn with no further
action required by the Company, and such Advance Notice shall be deemed automatically modified to reduce the amount of the Advance requested
by an amount equal to such withdrawn portion; provided that in the event of any such automatic withdrawal and automatic modification,
Investor will promptly notify the Company of such event. The Ownership Limitation may be waived by the Investor as to itself and its affiliates
upon not less than 65 days prior notice to the Company. During the term of this Agreement, the Investor on behalf of itself and its affiliates
hereby agrees not to acquire beneficial ownership any Common Shares, or securities convertible into Common Shares, to the extent such
acquisition would materially limit the Company’s ability to exercise its right to issue Advances hereunder.

 

		(ii)	Registration Limitation and Exchange Cap. In no event shall an Advance exceed the amount registered
under the Registration Statement then in effect (the “Registration Limitation”) or the Exchange Cap, to the extent
applicable. In connection with each Advance Notice, any portion of an Advance that would exceed the Registration Limitation or the Exchange
Cap shall automatically be withdrawn with no further action required by the Company and such Advance Notice shall be deemed automatically
modified to reduce the aggregate amount of the requested Advance by an amount equal to such withdrawn portion in respect of each Advance
Notice; provided that in the event of any such automatic withdrawal and automatic modification, Investor will promptly notify the Company
of such event.

 

    6 

     

    

 

		(d)	Minimum Acceptable Price.

 

		(i)	With respect to each Advance Notice, the Company may notify the Investor of the MAP with respect to such
Advance by indicating a MAP on such Advance Notice. If no MAP is specified in an Advance Notice, then no MAP shall be in effect in connection
with such Advance. Each Trading Day during a Pricing Period for which (A) with respect to each Advance Notice with a MAP, the VWAP of
the Common Shares is below the MAP in effect with respect to such Advance Notice, or (B) there is no VWAP (each such day, an “Excluded
Day”), shall result in an automatic reduction to the amount of the Advance set forth in such Advance Notice by one third (the
resulting amount of each Advance being the “Adjusted Advance Amount”), and each Excluded Day shall be excluded from
the Pricing Period for purposes of determining the Market Price.

 

		(ii)	The total Advance Shares in respect of each Advance (after reductions have been made to arrive at the
Adjusted Advance Amount, if any) shall be automatically increased by such number of Common Shares (the “Additional Shares”)
equal to the number of Common Shares sold by the Investor on such Excluded Day, if any, and the price paid per share for each Additional
Share shall be equal to the MAP in effect with respect to such Advance Notice (without any further discount), provided that this increase
shall not cause the total Advance to exceed the amount set forth in the original Advance Notice or any limitations set forth in Section
2.01(c).

 

		(e)	Unconditional Contract. Notwithstanding any other provision in this Agreement, the Company and
the Investor acknowledge and agree that upon the Investor’s receipt of a valid Advance Notice the parties shall be deemed to have
entered into an unconditional contract binding on both parties for the purchase and sale of Advance Shares pursuant to such Advance Notice
in accordance with the terms of this Agreement and (i) subject to Applicable Laws and (ii) subject to ‎Section 3.08 (Trading
Activities), the Investor may sell Common Shares during the Pricing Period.

 

Section 2.02Closings.
The closing of each Advance and each sale and purchase of Advance Shares (each, a “Closing”) shall take place as soon
as practicable on or after each Advance Date in accordance with the procedures set forth below. The parties acknowledge that the Purchase
Price is not known at the time the Advance Notice is delivered (at which time the Investor is irrevocably bound) but shall be determined
on each Closing based on the daily prices of the Common Shares that are the inputs to the determination of the Purchase Price as set forth
further below. In connection with each Closing, the Company and the Investor shall fulfill each of its obligations as set forth below:

 

		(a)	On each Advance Date, the Investor shall deliver to the Company a written document, in the form attached
hereto as Exhibit B (each a “Settlement Document”), setting forth the final number of Shares to be purchased by the
Investor (taking into account any adjustments pursuant to Section 2.01), the Market Price, the Purchase Price, the aggregate proceeds
to be paid by the Investor to the Company, and a report by Bloomberg, L.P. indicating the VWAP for each of the Trading Days during the
Pricing Period (or, if not reported on Bloomberg, L.P., another reporting service reasonably agreed to by the parties), in each case in
accordance with the terms and conditions of this Agreement.

 

    7 

     

    

 

		(b)	Promptly after receipt of the Settlement Document with respect to each Advance (and, in any event, not
later than one Trading Day after such receipt), the Company will, or will cause its transfer agent to, electronically transfer such number
of Advance Shares to be purchased by the Investor (as set forth in the Settlement Document) by crediting the Investor’s account
or its designee’s account at the Depository Trust Company through its Deposit Withdrawal at Custodian System or by such other means
of delivery as may be mutually agreed upon by the parties hereto, and transmit notification to the Investor that such share transfer has
been requested. Promptly upon receipt of such notification, the Investor shall pay to the Company the aggregate purchase price of the
Shares (as set forth in the Settlement Document) in cash in immediately available funds to an account designated by the Company in writing
and transmit notification to the Company that such funds transfer has been requested. No fractional shares shall be issued, and any fractional
amounts shall be rounded to the next higher whole number of shares. To facilitate the transfer of the Common Shares by the Investor, the
Common Shares will not bear any restrictive legends so long as there is an effective Registration Statement covering the resale of such
Common Shares (it being understood and agreed by the Investor that notwithstanding the lack of restrictive legends, the Investor may only
sell such Common Shares pursuant to the Plan of Distribution set forth in the Prospectus included in the Registration Statement and otherwise
in compliance with the requirements of the Securities Act (including any applicable prospectus delivery requirements) or pursuant to an
available exemption).

 

		(c)	On or prior to the Advance Date, each of the Company and the Investor shall deliver to the other all documents,
instruments and writings expressly required to be delivered by either of them pursuant to this Agreement in order to implement and effect
the transactions contemplated herein.

 

		(d)	Notwithstanding anything to the contrary in this Agreement, if on any day during the Pricing Period (i)
the Company notifies Investor that a Material Outside Event has occurred, or (ii) the Company notifies the Investor of a Black Out Period,
the parties agree that the pending Advance shall end and the final number of Advance Shares to be purchased by the Investor at the Closing
for such Advance shall be equal to the number of Common Shares sold by the Investor during the applicable Pricing Period prior to the
notification from the Company of a Material Outside Event or Black Out Period.

 

Section 2.03Hardship.

 

		(a)	In the event the Investor sells Common Shares of the Company after receipt of an Advance Notice and the
Company fails to perform its obligations as mandated in ‎Section 2.02, the Company agrees that in addition to and in no way limiting
the rights and obligations set forth in ‎Article V hereto and in addition to any other remedy to which the Investor is entitled at
law or in equity, including, without limitation, specific performance, it will hold the Investor harmless against any loss, claim, damage,
or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company
and acknowledges that irreparable damage may occur in the event of any such default. It is accordingly agreed that the Investor shall
be entitled to an injunction or injunctions to prevent such breaches of this Agreement and to specifically enforce (subject to the Securities
Act and other rules of the Principal Market), without the posting of a bond or other security, the terms and provisions of this Agreement.

 

    8 

     

    

 

		(b)	In the event the Company provides an Advance Notice and the Investor fails to perform its obligations
as mandated in ‎Section 2.02, the Investor agrees that in addition to and in no way limiting the rights and obligations set forth
in ‎Article V hereto and in addition to any other remedy to which the Company is entitled at law or in equity, including, without
limitation, specific performance, it will hold the Company harmless against any loss, claim, damage, or expense (including reasonable
legal fees and expenses), as incurred, arising out of or in connection with such default by the Investor and acknowledges that irreparable
damage may occur in the event of any such default. It is accordingly agreed that the Company shall be entitled to an injunction or injunctions
to prevent such breaches of this Agreement and to specifically enforce (subject to the Securities Act and other rules of the Principal
Market), without the posting of a bond or other security, the terms and provisions of this Agreement.

 

Section 2.04Completion
of Resale Pursuant to the Registration Statement. After the Investor has purchased the full Commitment Amount and has completed the
subsequent resale of all the Shares purchased hereunder pursuant to the Registration Statement, the Investor will notify the Company that
all subsequent resales are completed and the Company will be under no further obligation to maintain the effectiveness of the Registration
Statement.

 

Article III. Representations
and Warranties of Investor

 

The Investor represents and
warrants to the Company, as of the date hereof, as of each Advance Notice Date and each Advance Date that:

 

Section 3.01Organization
and Authorization. The Investor is duly organized, validly existing and in good standing under the laws of the Cayman Islands and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and to purchase or acquire
Shares in accordance with the terms hereof. The decision to invest and the execution and delivery of this Agreement by the Investor, the
performance by the Investor of its obligations hereunder and the consummation by the Investor of the transactions contemplated hereby
have been duly authorized and require no other proceedings on the part of the Investor. The undersigned has the right, power and authority
to execute and deliver this Agreement and all other instruments on behalf of the Investor or its shareholders. This Agreement has been
duly executed and delivered by the Investor and, assuming the execution and delivery hereof and acceptance thereof by the Company, will
constitute the legal, valid and binding obligations of the Investor, enforceable against the Investor in accordance with its terms.

 

Section 3.02Evaluation
of Risks. The Investor has such knowledge and experience in financial, tax and business matters as to be capable of evaluating the
merits and risks of, and bearing the economic risks entailed by, an investment in the Common Shares of the Company and of protecting its
interests in connection with the transactions contemplated hereby. The Investor acknowledges and agrees that its investment in the Company
involves a high degree of risk, and that the Investor may lose all or a part of its investment.

 

    9 

     

    

 

Section 3.03No Legal,
Investment or Tax Advice from the Company. The Investor acknowledges that it had the opportunity to review this Agreement and the
transactions contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor is relying solely
on such counsel and advisors and not on any statements or representations of the Company or any of the Company’s representatives
or agents for legal, tax, investment or other advice with respect to the Investor’s acquisition of Common Shares hereunder, the
transactions contemplated by this Agreement or the laws of any jurisdiction, and the Investor acknowledges that the Investor may lose
all or a part of its investment.

 

Section 3.04Investment
Purpose. The Investor is acquiring the Common Shares for its own account, for investment purposes and not with a view towards, or
for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt from the registration
requirements of the Securities Act; provided, however, that by making the representations herein, the Investor does not
agree, or make any representation or warranty, to hold any of the Shares for any minimum or other specific term and reserves the right
to dispose of the Shares at any time in accordance with, or pursuant to, a Registration Statement filed pursuant to this Agreement or
an applicable exemption under the Securities Act. The Investor does not presently have any agreement or understanding, directly or indirectly,
with any Person to sell or distribute any of the Shares. The Investor acknowledges that it will
be disclosed as an “underwriter” and a “selling stockholder” in each Registration Statement and in any prospectus
contained therein.

 

Section 3.05Accredited
Investor. The Investor is an “Accredited Investor” as that term is defined in Rule 501(a)(3) of Regulation D.

 

Section 3.06Information.
The Investor and its advisors (and its counsel), if any, have been furnished with all materials relating to the business, finances and
operations of the Company and information the Investor deemed material to making an informed investment decision. The Investor and its
advisors (and its counsel), if any, have been afforded the opportunity to ask questions of the Company and its management and have received
answers to such questions. Neither such inquiries nor any other due diligence investigations conducted by such Investor or its advisors
(and its counsel), if any, or its representatives shall modify, amend or affect the Investor’s right to rely on the Company’s
representations and warranties contained in this Agreement. The Investor acknowledges and agrees that the Company has not made to the
Investor, and the Investor acknowledges and agrees it has not relied upon, any representations and warranties of the Company, its employees
or any third party other than the representations and warranties of the Company contained in this Agreement. The Investor understands
that its investment involves a high degree of risk. The Investor has sought such accounting, legal and tax advice, as it has considered
necessary to make an informed investment decision with respect to the transactions contemplated hereby.

 

Section 3.07Not an Affiliate.
The Investor is not an officer, director or a person that directly, or indirectly through one or more intermediaries, controls or is controlled
by, or is under common control with the Company or any “Affiliate” of the Company (as that term is defined in Rule
405 promulgated under the Securities Act).

 

    10 

     

    

 

Section 3.08No Prior
Short Sales. At no time prior to the date of this Agreement has the Investor, its sole member, any of their respective officers, or
any entity managed or controlled by the Investor or its sole member, engaged in or effected, in any manner whatsoever, directly or indirectly,
for its own principal account, any (i) “short sale” (as such term is defined in Rule 200 of Regulation SHO of the Exchange
Act) of the Common Shares or (ii) hedging transaction, which establishes a net short position with respect to the Common Shares that
remains in effect as of the date of this Agreement.

 

Section 3.09General Solicitation.
Neither the Investor, nor any of its affiliates, nor any person acting on its or their behalf, has engaged or will engage in any form
of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or sale of the Common
Shares by the Investor.

 

Article IV. Representations
and Warranties of the Company

 

Except as set forth in the
SEC Documents, the Company represents and warrants to the Investor, as of the date hereof, each Advance Notice Date and each Advance Date
(other than representations and warranties which address matters only as of a certain date, which shall be true and correct as written
as of such certain date), that:

 

Section 4.01Organization
and Qualification. Each of the Company and its Subsidiaries (as defined below) is an entity duly organized and validly existing under
the laws of their respective jurisdiction of organization, and has the requisite power and authority to own its properties and to carry
on its business as now being conducted. Each of the Company and its Subsidiaries is duly qualified to do business and is in good standing
(to the extent applicable) in every jurisdiction in which the nature of the business conducted by it makes such qualification necessary,
except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse Effect.

 

Section 4.02Authorization,
Enforcement, Compliance with Other Instruments. The Company has the requisite corporate power and authority to enter into and perform
its obligations under this Agreement and the other Transaction Documents and to issue the Shares in accordance with the terms hereof and
thereof. The execution and delivery by the Company of this Agreement and the other Transaction Documents, and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares) have been
or (with respect to consummation) will be duly authorized by the Company’s board of directors and no further consent or authorization
will be required by the Company, its board of directors or its shareholders. This Agreement and the other Transaction Documents to which
it is a party have been (or, when executed and delivered, will be) duly executed and delivered by the Company and, assuming the execution
and delivery thereof and acceptance by the Investor, constitute (or, when duly executed and delivered, will be) the legal, valid and binding
obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability may
be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or other laws
relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification
and to contribution may be limited by federal or state securities law. “Transaction Documents” means, collectively,
this Agreement and each of the other agreements and instruments entered into or delivered by any of the parties hereto in connection with
the transactions contemplated hereby and thereby, as may be amended from time to time.

 

    11 

     

    

 

Section 4.03Authorization
of the Shares. The Shares to be issued under this Agreement have been, or with respect to Shares to be purchased by the Investor pursuant
to an Advance Notice, will be, when issued and delivered pursuant to the terms approved by the board of directors of the Company or a
duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, duly and validly
authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance, security interest or other claim,
including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar rights, and will be
registered pursuant to Section 12 of the Exchange Act. The Shares, when issued, will conform to the description thereof set forth in or
incorporated into the Prospectus.

 

Section 4.04No Conflict.
The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions
contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares) will not (i) result in a violation
of the articles of incorporation or other organizational documents of the Company or its Subsidiaries (with respect to consummation, as
the same may be amended prior to the date on which any of the transactions contemplated hereby are consummated), (ii) conflict with, or
constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights
of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or its Subsidiaries
is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws and regulations) applicable to the Company or its Subsidiaries or by which any property or asset of the Company or its Subsidiaries
is bound or affected except, in the case of clause (ii) or (iii) above, to the extent such violations that would not reasonably be expected
to have a Material Adverse Effect.

 

Section 4.05SEC Documents.
The Company has timely filed (giving effect to permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all reports,
schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the Exchange Act since October 14,
2021 (all of the foregoing filed since such date or amended after the date hereof, or filed after the date hereof, and all exhibits included
therein and financial statements and schedules thereto and documents incorporated by reference therein, and all registration statements
filed by the Company under the Securities Act (including any Registration statements filed hereunder and the Registration Statement on
Form S-4 declared effective by the SEC on July 5, 2022), being hereinafter referred to as the “SEC Documents”). The
Company has delivered or made available to the Investor through the SEC’s website at http://www.sec.gov, true and complete copies
of the SEC Documents. As of their respective dates (or, with respect to any filing that has been amended or superseded, the date of such
amendment or superseding filing), the SEC Documents complied in all material respects with the requirements of the Exchange Act or the
Securities Act, as applicable, and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and did
not contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

    12 

     

    

 

Section 4.06Financial
Statements. The consolidated financial statements of the Company included or incorporated by reference in SEC Documents, together
with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and
the Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity
of the Company for the periods specified and have been prepared in compliance with the requirements of the Securities Act and Exchange
Act and in conformity with generally accepted accounting principles in the United States (“GAAP”) applied on a consistent
basis (except for (i) such adjustments to accounting standards and practices as are noted therein, (ii) in the case of unaudited interim
financial statements, to the extent such financial statements may not include footnotes required by GAAP or may be condensed or summary
statements and (iii) such adjustments which will not be material, either individually or in the aggregate) during the periods involved;
the other financial and statistical data with respect to the Company and the Subsidiaries (as defined below) contained or incorporated
by reference in the SEC Documents are accurately and fairly presented and prepared on a basis consistent with the financial statements
and books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or
incorporated by reference in the SEC Documents that are not included or incorporated by reference as required; the Company and the Subsidiaries
(as defined below) do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations),
not described in the SEC Documents (excluding the exhibits thereto); and all disclosures contained or incorporated by reference in the
SEC Documents regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission)
comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent
applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the SEC Documents
fairly presents the information called for in all material respects and has been prepared in accordance with the SEC’s rules and
guidelines applicable thereto.

 

Section 4.07Registration
Statement and Prospectus. The Company and the transactions contemplated by this Agreement meet the requirements for and comply with
the conditions for the use of Form S-1 under the Securities Act. Each Registration Statement and the offer and sale of Shares as contemplated
hereby will meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule. Any statutes,
regulations, contracts or other documents that are required to be described in a Registration Statement or a Prospectus, or to be filed
as exhibits to a Registration Statement have been so described or filed. Copies of each Registration Statement, any Prospectus, and any
such amendments or supplements thereto and all documents incorporated by reference therein that were filed with the Commission on or prior
to the date of this Agreement have been delivered, or are available through EDGAR, to the Investor and its counsel. The Company has not
distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Shares, will not distribute
any offering material in connection with the offering or sale of the Shares other than a Registration Statement and the Prospectus and
any Issuer Free Writing Prospectus (as defined below) to which the Investor has consented.

 

    13 

     

    

 

Section 4.08No Misstatement
or Omission. Each Registration Statement, when it became or becomes effective, and any Prospectus, on the date of such Prospectus
or amendment or supplement, conformed and will conform in all material respects with the requirements of the Securities Act. At each Advance
Date, the Registration Statement, and the Prospectus, as of such date, will conform in all material respects with the requirements of
the Securities Act. Each Registration Statement, when it became or becomes effective, did not, and will not, contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
Each Prospectus did not, or will not, include an untrue statement of a material fact or omit to state a material fact necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading. The documents incorporated by reference
in a Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference therein will not,
when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required to be stated
in such document or necessary to make the statements in such document, in light of the circumstances under which they were made, not misleading.
The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information
furnished to the Company by the Investor specifically for use in the preparation thereof.

 

Section 4.09Conformity
with Securities Act and Exchange Act. Each Registration Statement, each Prospectus, or any amendment or supplement thereto, and the
documents incorporated by reference in each Registration Statement, Prospectus or any amendment or supplement thereto, when such documents
were or are filed with the SEC under the Securities Act or the Exchange Act or became or become effective under the Securities Act, as
the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable. 

 

Section 4.10Equity Capitalization.
As of the date hereof, the authorized capital of the Company consists of 975,000,000 shares of capital stock, consisting of 690,000,000
shares of Class A common stock, par value $0.0001 per share, 275,000,000 shares of Class V common stock, par value $0.0001 per share,
and 10,000,000 shares of preferred stock, par value $0.0001 per share. As of the date hereof, the Company had 49,514,239 shares of Class
A common stock, 111,340,411 shares of Class V common stock and no shares of preferred stock outstanding.

 

The Common Shares are registered
pursuant to Section 12(b) of the Exchange Act and is currently listed on a Principal Market under the trading symbol “RBT.”
The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Shares under
the Exchange Act, delisting the Common Shares from the Principal Market, nor has the Company received any notification that the Commission
or the Principal Market is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance
with all applicable listing requirements of the Principal Market.

 

    14 

     

    

 

Section 4.11Intellectual
Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses to use all material trademarks, trade
names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and rights, if any, necessary to conduct their respective businesses as now conducted, except
as would not cause a Material Adverse Effect. The Company and its Subsidiaries have not received written notice of any infringement by
the Company or its Subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names,
service marks, service mark registrations, or trade secrets, except as would not cause a Material Adverse Effect. To the knowledge of
the Company, there is no claim, action or proceeding being made or brought against, or to the Company’s knowledge, being threatened
against the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights, invention, copyright, license, service
names, service marks, service mark registrations, trade secret or other infringement; and, except as would not cause a Material Adverse
Effect, the Company is not aware of any facts or circumstances which might give rise to any of the foregoing.

 

Section 4.12Employee
Relations. Neither the Company nor any of its Subsidiaries is involved in any labor dispute nor, to the knowledge of the Company or
any of its Subsidiaries, is any such dispute threatened, in each case which is reasonably likely to cause a Material Adverse Effect.

 

Section 4.13Environmental
Laws. The Company and its Subsidiaries (i) have not received written notice alleging any failure to comply in all material respects
with all Environmental Laws (as defined below), (ii) have received all permits, licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses and (iii) have not received written notice alleging any failure to comply with
all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses (i), (ii) and (iii), the failure
to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The term “Environmental
Laws” means all applicable federal, state and local laws relating to pollution or protection of human health or the environment
(including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation,
laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous
substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture,
processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations,
codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations
issued, entered, promulgated or approved thereunder.

 

Section 4.14Title.
Except as would not cause a Material Adverse Effect, the Company (or its Subsidiaries) have indefeasible fee simple or leasehold title
to its properties and material assets owned by it, free and clear of any pledge, lien, security interest, encumbrance, claim or equitable
interest other than such as are not material to the business of the Company. Any real property and facilities held under lease by the
Company and its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material
and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its Subsidiaries.

 

Section 4.15Insurance.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries
are engaged. The Company has no reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have
a Material Adverse Effect.

 

    15 

     

    

 

Section 4.16Regulatory
Permits. The Company and each of its Subsidiaries possess or have applied for all certificates, authorizations and permits issued
by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates,
authorizations or permits would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, and neither
the Company nor any of its Subsidiaries has received any written notice of proceedings relating to the revocation or modification of any
such certificate, authorization or permit.

 

Section 4.17Internal
Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain
asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization
and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is
taken with respect to any differences, and management is not aware of any material weaknesses that are not disclosed in the SEC Documents
as and when required.

 

Section 4.18Absence of
Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending against or affecting the Company, the Common Shares or any of the Company’s Subsidiaries,
wherein an unfavorable decision, ruling or finding would have a Material Adverse Effect.

 

Section 4.19Subsidiaries.
The Company does not presently own or control, directly or indirectly, any interest in any other corporation, partnership, association
or other business entity.

 

Section 4.20Tax Status.
Each of the Company and its Subsidiaries (i) has timely made or filed all foreign, federal and state income and all other tax returns,
reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes and other governmental assessments
and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested
in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to
the periods to which such returns, reports or declarations apply. The Company has not received written notification any unpaid taxes in
any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company and its Subsidiaries
know of no basis for any such claim where failure to pay would cause a Material Adverse Effect.

 

Section 4.21Certain Transactions.
Except as not required to be disclosed pursuant to Applicable Laws, none of the officers or directors of the Company is presently a party
to any transaction with the Company (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
or otherwise requiring payments to or from any officer or director, or to the knowledge of the Company, any corporation, partnership,
trust or other entity in which any officer or director has a substantial interest or is an officer, director, trustee or partner.

 

    16 

     

    

 

Section 4.22Rights of
First Refusal. The Company is not obligated to offer the Common Shares offered hereunder on a right of first refusal basis or otherwise
to any third parties including, but not limited to, current or former shareholders of the Company, underwriters, brokers, agents or other
third parties.

 

Section 4.23Dilution.
The Company is aware and acknowledges that issuance of Common Shares hereunder could cause dilution to existing shareholders and could
significantly increase the outstanding number of Common Shares.

 

Section 4.24Acknowledgment
Regarding Investor’s Purchase of Shares. The Company acknowledges and agrees that the Investor is acting solely in the capacity
of an arm’s length investor with respect to this Agreement and the transactions contemplated hereunder. The Company further acknowledges
that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement
and the transactions contemplated hereunder and any advice given by the Investor or any of its representatives or agents in connection
with this Agreement and the transactions contemplated hereunder is merely incidental to the Investor’s purchase of the Shares hereunder.
The Company is aware and acknowledges that it shall not be able to request Advances under this Agreement if the Registration Statement
is not effective or if any issuances of Common Shares pursuant to any Advances would violate any rules of the Principal Market. The Company
acknowledged and agrees that it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions
of the transactions contemplated by this Agreement.

 

Section 4.25Finder’s
Fees. Neither the Company nor any of the Subsidiaries has incurred any liability for any finder’s fees, brokerage commissions
or similar payments in connection with the transactions herein contemplated. 

 

Section 4.26Relationship
of the Parties. Neither the Company, nor any of its subsidiaries, affiliates, nor any person acting on its or their behalf is a client
or customer of the Investor or any of its affiliates and neither the Investor nor any of its affiliates has provided, or will provide,
any services to the Company or any of its affiliates, its subsidiaries, or any person acting on its or their behalf. The Investor’s
relationship to Company is solely as investor as provided for in the Transaction Documents. 

 

Section 4.27Operations.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with
Applicable Law.

 

Section 4.28Forward-Looking
Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in the Registration Statement or a Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed
other than in good faith.

 

Section 4.29Compliance
with Laws. The Company and each of its Subsidiaries are in compliance in all material respects with Applicable Laws and the Company
has not received written notice of material non-compliance with Applicable Laws. To the knowledge of the Company, the directors, officers,
employees and agents of the Company and its Subsidiaries are in compliance in all material respects with Applicable Laws.

 

    17 

     

    

 

Section 4.30Sanctions
Matters. Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, any director, officer or controlled
affiliate of the Company or any director or officer of any Subsidiary, is a Person that is, or is owned or controlled by a Person that
is (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Asset Control
(“OFAC”), the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant
sanctions authorities, including, without limitation, designation on OFAC’s Specially Designated Nationals and Blocked Persons List
or OFAC’s Foreign Sanctions Evaders List or other relevant sanctions authority (collectively, “Sanctions”), or
(ii) located, organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with
that country or territory (including, without limitation, the Crimea region, the Donetsk People’s Republic and Luhansk People’s
Republic in Ukraine, Cuba, Iran, North Korea, Sudan and Syria (the “Sanctioned Countries”)). Neither the Company nor
any of its Subsidiaries will, directly or indirectly, use the proceeds from the sale of Advance Shares, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other Person (a) for the purpose of funding or facilitating
any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is
the subject of Sanctions or is a Sanctioned Country, or (b) in any other manner that will result in a violation of Sanctions or Applicable
Laws by any Person (including any Person participating in the transactions contemplated by this Agreement, whether as underwriter, advisor,
investor or otherwise). For the past five years, neither the Company nor any of its Subsidiaries has engaged in, and is now not engaged
in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or
was the subject of Sanctions or was a Sanctioned Country.

 

Article V. Indemnification

 

The Investor and the Company
represent to the other the following with respect to itself:

 

Section 5.01Indemnification
by the Company. In consideration of the Investor’s execution and delivery of this Agreement and acquiring the Shares hereunder,
and in addition to all of the Company’s other obligations under this Agreement, the Company shall defend, protect, indemnify and
hold harmless the Investor and its investment manager, Yorkville Advisors Global, LP, and each of their respective officers, directors,
managers, members, partners, employees and agents (including, without limitation, those retained in connection with the transactions contemplated
by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act (collectively, the “Investor Indemnitees”) from and against any and all actions, causes of action, suits,
claims, losses, costs, penalties, fees, liabilities and damages, and reasonable and documented expenses in connection therewith (irrespective
of whether any such Investor Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by the Investor Indemnitees or any
of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus,
or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however,
that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is
based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in
conformity with written information furnished to the Company by or on behalf of the Investor specifically for inclusion therein; (b) any
material misrepresentation or breach of any material representation or material warranty made by the Company in this Agreement or any
other certificate, instrument or document contemplated hereby or thereby; or (c) any material breach of any material covenant, material
agreement or material obligation of the Company contained in this Agreement or any other certificate, instrument or document contemplated
hereby or thereby. To the extent that the foregoing undertaking by the Company may be unenforceable under Applicable Law, the Company
shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under
Applicable Law.

 

    18 

     

    

 

Section 5.02Indemnification
by the Investor. In consideration of the Company’s execution and delivery of this Agreement, and in addition to all of the Investor’s
other obligations under this Agreement, the Investor shall defend, protect, indemnify and hold harmless the Company and all of its officers,
directors, shareholders, employees and agents (including, without limitation, those retained in connection with the transactions contemplated
by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act (collectively, the “Company Indemnitees”) from and against any and all Indemnified Liabilities incurred
by the Company Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement for the registration of the Shares as originally filed or in any
amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arise out of or are based upon
the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein
not misleading; provided, however, that the Investor will only be liable for written information relating to the Investor
furnished to the Company by or on behalf of the Investor specifically for inclusion in the documents referred to in the foregoing indemnity,
and will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any
such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with
written information furnished to the Investor by or on behalf of the Company specifically for inclusion therein; (b) any misrepresentation
or breach of any representation or warranty made by the Investor in this Agreement or any instrument or document contemplated hereby or
thereby executed by the Investor; or (c) any breach of any covenant, agreement or obligation of the Investor contained in this Agreement
or any other certificate, instrument or document contemplated hereby or thereby executed by the Investor To the extent that the foregoing
undertaking by the Investor may be unenforceable under Applicable Laws, the Investor shall make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities, which is permissible under Applicable Laws.

 

    19 

     

    

 

Section 5.03Notice of
Claim. Promptly after receipt by an Investor Indemnitee or Company Indemnitee of notice of the commencement of any action or proceeding
(including any governmental action or proceeding) involving an Indemnified Liability, such Investor Indemnitee or Company Indemnitee,
as applicable, shall, if a claim for an Indemnified Liability in respect thereof is to be made against any indemnifying party under this
‎Article V, deliver to the indemnifying party a written notice of the commencement thereof; but the failure to so notify the indemnifying
party will not relieve it of liability under this ‎Article V except to the extent the indemnifying party is prejudiced by such failure.
The indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any
other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually reasonably satisfactory to
the indemnifying party and the Investor Indemnitee or Company Indemnitee, as the case may be; provided, however, that an Investor Indemnitee
or Company Indemnitee shall have the right to retain its own counsel with the actual and reasonable third party fees and expenses of not
more than one counsel for such Investor Indemnitee or Company Indemnitee to be paid by the indemnifying party, if, in the reasonable opinion
of counsel retained by the indemnifying party, the representation by such counsel of the Investor Indemnitee or Company Indemnitee and
the indemnifying party would be inappropriate due to actual or potential differing interests between such Investor Indemnitee or Company
Indemnitee and any other party represented by such counsel in such proceeding. The Investor Indemnitee or Company Indemnitee shall cooperate
fully with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party
and shall furnish to the indemnifying party all information reasonably available to the Investor Indemnitee or Company Indemnitee which
relates to such action or claim. The indemnifying party shall keep the Investor Indemnitee or Company Indemnitee reasonably apprised as
to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement
of any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying party shall not
unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the Investor
Indemnitee or Company Indemnitee, consent to entry of any judgment or enter into any settlement or other compromise which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to such Investor Indemnitee or Company Indemnitee of a release
from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party
shall be subrogated to all rights of the Investor Indemnitee or Company Indemnitee with respect to all third parties, firms or corporations
relating to the matter for which indemnification has been made. The indemnification required by this ‎Article V shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received and payment therefor
is due.

 

Section 5.04Remedies.
The remedies provided for in this Article V are not exclusive and shall not limit any right or remedy which may be available to any indemnified
person at law or equity. The obligations of the parties to indemnify or make contribution under this ‎Article V shall survive expiration
or termination of this Agreement.

 

Section 5.05Limitation
of liability. Notwithstanding the foregoing, no party shall be entitled to recover from the other party for punitive, indirect, incidental
or consequential damages.

 

    20 

     

    

 

Article VI.

Covenants

 

The Company covenants with the
Investor, and the Investor covenants with the Company, as follows, which covenants of one party are for the benefit of the other party,
during the Commitment Period:

 

Section 6.01Registration
Statement.

 

		(a)	Filing of a Registration Statement. The Company shall prepare and file with the SEC a Registration
Statement, or multiple Registration Statements for the resale by the Investor of the Registrable Securities. The Company in its sole discretion
may choose when to file such Registration Statements; provided, however, that the Company shall not have the ability to request
any Advances until the effectiveness of a Registration Statement.

 

		(b)	Maintaining a Registration Statement. The Company shall use commercially reasonable efforts to
maintain the effectiveness of any Registration Statement that has been declared effective at all times during the Commitment Period, provided,
however, that if the Company has received notification pursuant to Section 2.04 that the Investor has purchased the full Commitment Amount
and has completed the subsequent resale of all the Shares purchased hereunder pursuant to the Registration Statement, then the Company
shall be under no further obligation to maintain the effectiveness of the Registration Statement. Notwithstanding anything to the contrary
contained in this Agreement, the Company shall ensure that, when filed, each Registration Statement (including, without limitation, all
amendments and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto) used in
connection with such Registration Statement shall not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances
in which they were made) not misleading. During the Commitment Period, the Company shall notify the Investor promptly if (i) the Registration
Statement shall cease to be effective under the Securities Act, (ii) the Common Shares shall cease to be authorized for listing on the
Principal Market, (iii) the Common Shares cease to be registered under Section 12(b) or Section 12(g) of the Exchange Act or (iv)
the Company fails to file in a timely manner all reports and other documents required of it as a reporting company under the Exchange
Act.

 

		(c)	Filing Procedures. The Company shall (A) permit counsel to the Investor an opportunity to
review and comment upon (i) each Registration Statement at least three (3) Trading Days prior to its filing with the SEC and
(ii) all amendments and supplements to each Registration Statement (including, without limitation, the Prospectus contained therein)
(except for amendments, post-effective amendments, or supplements with respect to Annual Reports on Form 10-K, Quarterly Reports
on Form 10-Q, Current Reports on Form 8-K, and any similar or successor reports, and amendments to selling securityholders
listed in such Registration Statement) within a reasonable number of days prior to their filing with the SEC, and (B) shall reasonably
consider any comments of the Investor and its counsel on any such Registration Statement or amendment or supplement thereto or to any
Prospectus contained therein. The Company shall promptly furnish to the Investor, without charge, (i) electronic copies of any correspondence
from the SEC or the Staff to the Company or its representatives relating to each Registration Statement (which correspondence shall be
redacted to exclude any material, non-public information regarding the Company or any of its Subsidiaries), (ii) after the same
is prepared and filed with the SEC, one (1) electronic copy of each Registration Statement and any amendment(s) and supplement(s)
thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested
by the Investor, and all exhibits and (iii) upon the effectiveness of each Registration Statement, one (1) electronic copy of
the Prospectus included in such Registration Statement and all amendments and supplements thereto; provided, however, the Company shall
not be required to furnish any document to the extent such document is available on EDGAR).

 

    21 

     

    

 

		(d)	Amendments and Other Filings. The Company shall (i) prepare and file with the SEC such amendments (including
post-effective amendments) and supplements to a Registration Statement and the related prospectus used in connection with such Registration
Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep such
Registration Statement effective at all times during the Commitment Period, and prepare and file with the SEC such additional Registration
Statements in order to register for resale under the Securities Act all of the Registrable Securities; (ii) cause the related prospectus
to be amended or supplemented by any required prospectus supplement (subject to the terms of this Agreement), and as so supplemented or
amended to be filed pursuant to Rule 424 promulgated under the Securities Act; (iii) provide the Investor copies of all correspondence
from and to the SEC relating to a Registration Statement (provided that the Company may excise any information contained therein which
would constitute material non-public information, and (iv) comply with the provisions of the Securities Act with respect to the disposition
of all Common Shares of the Company covered by such Registration Statement until such time as all of such Common Shares shall have been
disposed of in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration
Statement. In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement
(including pursuant to this ‎Section 6.01(d) by reason of the Company’s filing a report on Form 10-K, Form 10-Q, or Form 8-K
or any analogous report under the Exchange Act, the Company shall file such report in a prospectus supplement filed pursuant to Rule 424
promulgated under the Securities Act to incorporate such filing into the Registration Statement, if applicable, or shall file such amendments
or supplements with the SEC either on the day on which the Exchange Act report is filed which created the requirement for the Company
to amend or supplement the Registration Statement, if feasible, or otherwise promptly thereafter.

 

		(e)	Blue-Sky. The Company shall use its commercially reasonable efforts to, if required by Applicable
Laws, (i) register and qualify the Common Shares covered by a Registration Statement under such other securities or “blue sky”
laws of such jurisdictions in the United States as the Investor reasonably requests, (ii) prepare and file in those jurisdictions,
such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be necessary to
maintain the effectiveness thereof during the Commitment Period, (iii) take such other actions as may be necessary to maintain such registrations
and qualifications in effect at all times during the Commitment Period, and (iv) take all other actions reasonably necessary or advisable
to qualify the Common Shares for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith
or as a condition thereto to (w) make any change to its Articles of Incorporation or Bylaws or any other organizational documents of the
Company or any of its Subsidiaries, (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify
but for this Section 6.01, (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of
process in any such jurisdiction. The Company shall promptly notify the Investor of the receipt by the Company of any notification with
respect to the suspension of the registration or qualification of any of the Common Shares for sale under the securities or “blue
sky” laws of any jurisdiction in the United States or its receipt of actual notice of the initiation or threat of any proceeding
for such purpose.

 

    22 

     

    

 

Section 6.02Suspension
of Registration Statement.

 

		(a)	Establishment of a Black Out Period. During the Commitment Period, the Company from time to time
may suspend the use of the Registration Statement by written notice to the Investor in the event that the Company determines in its sole
discretion in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic information concerning the
Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company or
(B) amend or supplement the Registration Statement or Prospectus so that such Registration Statement or Prospectus shall not include an
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading (a “Black Out Period”).

 

		(b)	No Sales by Investor During the Black Out Period. During such Black Out Period, the Investor agrees
not to sell any Common Shares of the Company pursuant to such Registration Statement, but may sell shares pursuant to an exemption from
registration, if available, subject to the Investor’s compliance with Applicable Laws.

 

		(c)	Limitations on the Black Out Period. The Company shall not impose any Black Out Period that is
longer than 60 days or in a manner that is more restrictive (including, without limitation, as to duration) than the comparable restrictions
that the Company may impose on transfers of the Company’s equity securities by its directors and senior executive officers. In addition,
the Company shall not deliver any Advance Notice during any Black Out Period. If the public announcement of such material, nonpublic information
is made during a Black Out Period, the Black Out Period shall terminate immediately after such announcement, and the Company shall immediately
notify the Investor of the termination of the Black Out Period.

 

Section 6.03Listing of
Common Shares. As of each Advance Date, the Shares to be sold by the Company from time to time hereunder will have been registered
under Section 12(b) of the Exchange Act and approved for listing on the Principal Market, subject to official notice of issuance.

 

    23 

     

    

 

Section 6.04Opinion of
Counsel. Prior to the date of the delivery by the Company of the first Advance Notice, the Investor shall have received an opinion
letter from counsel to the Company in form substantially similar to the form set forth on Exhibit C.

 

Section 6.05Exchange
Act Registration. The Company will file in a timely manner all reports and other documents required of it as a reporting company under
the Exchange Act and will not take any action or file any document (whether or not permitted by Exchange Act or the rules thereunder)
to terminate or suspend its reporting and filing obligations under the Exchange Act.

 

Section 6.06Transfer
Agent Instructions. For any time while there is a Registration Statement in effect for this transaction, the Company shall (if required
by the transfer agent for the Common Shares) cause legal counsel for the Company to deliver to the transfer agent for the Common Shares
(with a copy to the Investor) instructions to issue Common Shares to the Investor free of restrictive legends upon each Advance if the
delivery of such instructions are consistent with Applicable Law.

 

Section 6.07Corporate
Existence. The Company will use commercially reasonable efforts to preserve and continue the corporate existence of the Company during
the Commitment Period.

 

Section 6.08Notice of
Certain Events Affecting Registration; Suspension of Right to Make an Advance. The Company will promptly notify the Investor, and
confirm in writing, upon its becoming aware of the occurrence of any of the following events in respect of a Registration Statement or
related Prospectus (in each of which cases the information provided to Investor will be kept strictly confidential but also provided that
in no event shall such notice contain any material, nonpublic information)): (i) except for requests made in connection with SEC investigations
disclosed in the SEC Documents, receipt of any request for additional information by the SEC or any other Federal or state governmental
authority during the period of effectiveness of the Registration Statement or any request for amendments or supplements to the Registration
Statement or related Prospectus; (ii) the issuance by the SEC or any other Federal governmental authority of any stop order suspending
the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the Common Shares for sale in any jurisdiction
or the initiation or written threat of any proceeding for such purpose; (iv) the happening of any event that makes any statement made
in the Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue
in any material respect or that requires the making of any changes in the Registration Statement, related Prospectus or documents so that,
in the case of the Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein not misleading, and that in the case of the related Prospectus,
it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, or of the necessity to amend
the Registration Statement or supplement a related Prospectus to comply with the Securities Act or any other law; (v) the Company’s
reasonable determination that a post-effective amendment to the Registration Statement would be required and the Company will promptly
make available to the Investor any such supplement or amendment to the related Prospectus; (vi) the Common Shares shall cease to be authorized
for listing on the Principal Market; or (vii) the Company fails to file in a timely manner all reports and other documents required of
it as a reporting company under the Exchange Act. The Company shall not deliver to the Investor any Advance Notice, and the Company shall
not sell any Shares pursuant to any pending Advance Notice (other than as required pursuant to Section 2.02(d)), during the continuation
of any of the foregoing events (each of the events described in the immediately preceding clauses (i) through (vii), inclusive, a “Material
Outside Event”).

 

    24 

     

    

 

Section 6.09Consolidation.
If an Advance Notice has been delivered to the Investor, then the Company shall not effect any consolidation of the Company with or into,
or a transfer of all or substantially all the assets of the Company to another entity before the transaction contemplated in such Advance
Notice has been closed in accordance with Section 2.02 hereof, and all Shares in connection with such Advance have been received by the
Investor.

 

Section 6.10Issuance
of the Company’s Common Shares. The issuance and sale of the Common Shares hereunder shall be made in accordance with the provisions
and requirements of Section 4(a)(2) of the Securities Act and any applicable state securities law.

 

Section 6.11Expenses.
The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay all expenses
incident to the performance of its obligations hereunder, including but not limited to (i) the preparation, printing and filing of the
Registration Statement and each amendment and supplement thereto, of each prospectus and of each amendment and supplement thereto; (ii)
the preparation, issuance and delivery of any Shares issued pursuant to this Agreement, (iii) all fees and disbursements of the Company’s
counsel, accountants and other advisors (but not, for the avoidance doubt, the fees and disbursements of Investor’s counsel, accountants
and other advisors), (iv) the qualification of the Shares under securities laws in accordance with the provisions of this Agreement, including
filing fees in connection therewith, (v) the printing and delivery of copies of any prospectus and any amendments or supplements thereto,
(vi) the fees and expenses incurred in connection with the listing or qualification of the Shares for trading on the Principal Market,
or (vii) filing fees of the SEC and the Principal Market. Investor shall pay any transfer or other taxes and duties levied in connection
with the resale of the Shares purchased hereunder

 

Section 6.12Current Report.
The Company shall, not later than 9:00 a.m., New York City time, on the fourth business day after the date of this Agreement, file with
the SEC a Current Report on Form 8-K disclosing the execution of this Agreement by the Company and the Investor (including any
exhibits thereto, the “Current Report”). The Company shall provide the Investor and its legal counsel a reasonable
opportunity to comment on a draft of the Current Report prior to filing the Current Report with the SEC and shall give due consideration
to all such comments. From and after the filing of the Current Report with the SEC, the Company shall have publicly disclosed all material,
nonpublic information delivered to the Investor (or the Investor’s representatives or agents) by the Company or any of its Subsidiaries,
or any of their respective officers, directors, employees, agents or representatives (if any) in connection with the transactions contemplated
by the Transaction Documents. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their
respective officers, directors, employees and agents not to, provide the Investor with any material, non-public information regarding
the Company or any of its Subsidiaries without the express prior written consent of the Investor (which may be granted or withheld in
the Investor’s sole discretion); it being understood that the mere notification of Investor required pursuant to ‎Section 6.08(iv)
hereof shall not in and of itself be deemed to be material non-public information. Notwithstanding anything contained in this Agreement
to the contrary, the Company expressly agrees that it shall publicly disclose in the Current Report any information communicated to the
Investor by or, to the knowledge of the Company, on behalf of the Company in connection with the transactions contemplated herein, which,
following the date hereof would, if not so disclosed, constitute material, non-public information regarding the Company or its Subsidiaries.
The Company understands and confirms that the Investor will reply on the foregoing representations in effecting resales of Shares under
the Registration Statement.

 

    25 

     

    

 

Section 6.13Advance Notice
Limitation. The Company shall not deliver an Advance Notice if a shareholder meeting or corporate action date, or the record date
for any shareholder meeting or any corporate action, would fall during the period beginning two Trading Days prior to the date of delivery
of such Advance Notice and ending two Trading Days following the Closing of such Advance.

 

Section 6.14Use of Proceeds.
The proceeds from the sale of the Shares by the Company to Investor shall be used by the Company in the manner as will be set forth in
the Prospectus included in any Registration Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto
filed pursuant to this Agreement.

 

Section 6.15Compliance
with Laws. The Company shall comply in all material respects with all Applicable Laws.

 

Section 6.16Market Activities.
Neither the Company, nor any Subsidiary, nor any of their respective officers, directors or controlling persons will, directly or indirectly,
(i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute or result,
in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Shares or
(ii) sell, bid for, or purchase Common Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases
of the Shares.

 

Section 6.17Trading Information.
Upon the Company’s request, the Investor agrees to provide the Company with trading reports setting forth the number and average
sales prices of shares of Common Stock sold by the Investor during the prior trading week.

 

Section 6.18Selling Restrictions.
(i) Except as expressly set forth below, the Investor covenants that from and after the date hereof through and including the Trading
Day next following the expiration or termination of this Agreement as provided in ‎Section 10.01 (the “Restricted Period”),
none of the Investor any of its officers, or any entity managed or controlled by the Investor (collectively, the “Restricted
Persons” and each of the foregoing is referred to herein as a “Restricted Person”) shall, directly or indirectly,
engage in any “short sale” (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Shares,
either for its own principal account or for the principal account of any other Restricted Person. Notwithstanding the foregoing, it is
expressly understood and agreed that nothing contained herein shall (without implication that the contrary would otherwise be true) prohibit
any Restricted Person during the Restricted Period from: (1) selling “long” (as defined under Rule 200 promulgated under
Regulation SHO) the Shares; or (2) selling a number of Common Shares equal to the number of Advance Shares that such Restricted Person
is unconditionally obligated to purchase under a pending Advance Notice but has not yet received from the Company or the transfer agent
pursuant to this Agreement.

 

    26 

     

    

 

Section 6.19Assignment.
Neither this Agreement nor any rights or obligations of the parties hereto may be assigned to any other Person.

 

Section 6.20Non-Public
Information. The Company covenants and agrees that, other than as expressly required by ‎Section 6.08 hereof, or, with the Investor’s
consent pursuant to ‎Section 6.12, it shall refrain from disclosing, and shall cause its officers, directors, employees and agents
to refrain from disclosing, any material non-public information (as determined under the Securities Act, the Exchange Act, or the rules
and regulations of the SEC) to the Investor without also disseminating such information to the public, unless prior to disclosure of such
information the Company identifies such information as being material non-public information and provides the Investor with the opportunity
to accept or refuse to accept such material non-public information for review. Unless specifically agreed to in writing, in no event shall
the Investor have a duty of confidentiality, or be deemed to have agreed to maintain information in confidence, with respect to the delivery
of any Advance Notices.

 

Article VII.

Conditions for Delivery of Advance Notice

 

Section 7.01Conditions
Precedent to the Right of the Company to Deliver an Advance Notice. The right of the Company to deliver an Advance Notice and the
obligations of the Investor hereunder with respect to an Advance are subject to the satisfaction or waiver, on each Advance Notice Date
(a “Condition Satisfaction Date”), of each of the following conditions:

 

		(a)	Accuracy of the Company’s Representations and Warranties. The representations and warranties
of the Company in this Agreement shall be true and correct in all material respects.

 

		(b)	Registration of the Common Shares with the SEC. There is an effective Registration Statement pursuant
to which the Investor is permitted to utilize the prospectus thereunder to resell all of the Common Shares issuable pursuant to such Advance
Notice. The Company shall have filed with the SEC in a timely manner all reports, notices and other documents required under the Exchange
Act and applicable SEC regulations during the twelve-month period immediately preceding the applicable Condition Satisfaction Date.

 

		(c)	Authority. The Company shall have obtained all permits and qualifications required by any applicable
state for the offer and sale of all the Common Shares issuable pursuant to such Advance Notice, or shall have the availability of exemptions
therefrom. The sale and issuance of such Common Shares shall be legally permitted by all laws and regulations to which the Company is
subject.

 

		(d)	No Material Outside Event. No Material Outside Event shall have occurred and be continuing.

 

    27 

     

    

 

		(e)	Performance by the Company. The Company shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company
at or prior the applicable Condition Satisfaction Date.

 

		(f)	No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall
have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits or
directly, materially and adversely affects any of the transactions contemplated by this Agreement.

 

		(g)	No Suspension of Trading in or Delisting of Common Shares. The Common Shares are quoted for trading
on the Principal Market and all of the Shares issuable pursuant to such Advance Notice will be listed or quoted for trading on the Principal
Market. The issuance of Common Shares with respect to the applicable Advance Notice will not violate the shareholder approval requirements
of the Principal Market. The Company shall not have received any written notice that is then still pending threatening the continued quotation
of the Common Shares on the Principal Market.

 

		(h)	Authorized. There shall be a sufficient number of authorized but unissued and otherwise unreserved
Common Shares for the issuance of all of the Shares issuable pursuant to such Advance Notice.

 

		(i)	Executed Advance Notice. The representations contained in the applicable Advance Notice shall be
true and correct in all material respects as of the applicable Condition Satisfaction Date.

 

		(j)	Consecutive Advance Notices. Except with respect to the first Advance Notice, the Company shall
have delivered all Shares relating to all prior Advances, and at least 5 Trading Days shall have elapsed from the immediately preceding
Advance Date.

 

Article VIII.

Non Exclusive Agreement

 

Notwithstanding anything contained
herein, this Agreement and the rights awarded to the Investor hereunder are non-exclusive, and the Company may, at any time throughout
the term of this Agreement and thereafter, issue and allot, or undertake to issue and allot, any shares and/or securities and/or convertible
notes, bonds, debentures, options to acquire shares or other securities and/or other facilities which may be converted into or replaced
by Common Shares or other securities of the Company, and to extend, renew and/or recycle any bonds and/or debentures, and/or grant any
rights with respect to its existing and/or future share capital.

 

Article IX.

Choice of Law/Jurisdiction

 

This Agreement shall be governed
by and interpreted in accordance with the laws of the State of New York without regard to the principles of conflict of laws. The parties
further agree that any action between them shall be heard in New York County, New York, and expressly consent to the jurisdiction and
venue of the Supreme Court of New York, sitting in New York County, New York and the United States District Court of the Southern District
of New York, sitting in New York, New York, for the adjudication of any civil action asserted pursuant to this Agreement.

 

    28 

     

    

 

Article X. Termination

 

Section 10.01Termination.

 

		(a)	Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest
of (i) the first day of the month next following the 36-month anniversary of the date hereof or (ii) the date on which the Investor
shall have purchased Shares under this Agreement in an amount equal to the full Commitment Amount.

 

		(b)	The Company may terminate this Agreement effective upon five Trading Days’ prior written notice
to the Investor; provided that (i) there are no outstanding Advance Notices, the Common Shares under which have yet to be issued, and
(ii) the Company has paid all amounts owed to the Investor pursuant to this Agreement. This Agreement may be terminated at any time by
the mutual written consent of the parties, effective as of the date of such mutual written consent unless otherwise provided in such written
consent.

 

		(c)	Nothing in this ‎Section 10.01 shall be deemed to release the Company or the Investor from any liability
for any breach under this Agreement, or to impair the rights of the Company and the Investor to compel specific performance by the other
party of its obligations under this Agreement. The indemnification provisions contained in ‎Article V shall survive termination hereunder.

 

Article XI. Notices

 

Other than with respect to
Advance Notices, which must be in writing and will be deemed delivered on the day set forth in Section 2.01(b), any notices, consents,
waivers, or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed
to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile or e-mail if sent on a Trading
Day, or, if not sent on a Trading Day, on the immediately following Trading Day; (iii) 5 days after being sent by U.S. certified mail,
return receipt requested, (iv) 1 day after deposit with a nationally recognized overnight delivery service, in each case properly addressed
to the party to receive the same. The addresses and facsimile numbers for such communications (except for Advance Notices which shall
be delivered in accordance with Exhibit A hereof) shall be:

 

	
    If to the Company, to:
	
    Rubicon Technologies, Inc.

    100 W Main Street

    Suite 610

    Lexington, KY 40507

	 	Attention: General Counsel
	 	
    Email: bill.meyer@rubicon.com

 

    29 

     

    

 

	
    With a copy to (which shall not

    constitute notice or delivery of process) to:
	 
	 	 
	 	
    Gibson, Dunn & Crutcher LLP

    555 Mission Street, Suite 3000

    San Francisco, CA 94105-0921

    Attention: Stewart McDowell; Evan D’Amico

    E-Mail: smcdowell@gibsondunn.com; edamico@gibsondunn.com

	 	
     

	If to the Investor(s):	YA II PN, Ltd.
	 	1012 Springfield Avenue
	 	Mountainside, NJ 07092
	 	Attention:	Mark Angelo                                     
	 		Portfolio Manager
	 	Telephone:	(201) 985-8300
	 	
    Email:mangelo@yorkvilleadvisors.com

	 	 
	
    With a Copy (which shall not

    constitute notice or delivery of process) to:
	
    David Fine, Esq.

    1012 Springfield Avenue

    Mountainside, NJ 07092

	 	Telephone:  	(201) 985-8300
	 	Email: 	legal@yorkvilleadvisors.com

 

or at such other address and/or e-mail and/or
to the attention of such other person as the recipient party has specified by written notice given to each other party three Business
Days prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient of such notice, consent, waiver
or other communication, (ii) electronically generated by the sender’s email service provider containing the time, date, recipient
email address or (iii) provided by a nationally recognized overnight delivery service shall be rebuttable evidence of personal service,
receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above,
respectively.

 

Article XII. Miscellaneous

 

Section 12.01Counterparts.
This Agreement may be executed in identical counterparts, both which shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically scanned and delivered
signatures (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the
Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com), including by e-mail attachment, shall be
deemed to have been duly and validly delivered and be valid and effective for all purposes of this Agreement.

 

    30 

     

    

 

Section 12.02Entire Agreement;
Amendments. This Agreement supersedes all other prior oral or written agreements between the Investor, the Company, their respective
affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement contains the entire understanding
of the parties with respect to the matters covered herein and, except as specifically set forth herein, neither the Company nor the Investor
makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be waived
or amended other than by an instrument in writing signed by the parties to this Agreement.

 

Section 12.03Reporting
Entity for the Common Shares. The reporting entity relied upon for the determination of the trading price or trading volume of the
Common Shares on any given Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor thereto. The written
mutual consent of the Investor and the Company shall be required to employ any other reporting entity.

 

Section 12.04Commitment
and Structuring Fee. Each of the parties shall pay its own fees and expenses (including the fees of any attorneys, accountants,
appraisers or others engaged by such party) in connection with this Agreement and the transactions contemplated hereby, except that the
Company shall pay to YA Global II SPV, LLC, a subsidiary of the Investor, a structuring fee in the amount of $10,000 on the date hereof
and, on the date hereof, the Company will issue to the Investor an aggregate of 200,000 Common Shares (the “Commitment Fee Shares”)
as a commitment fee.

 

Section 12.05Brokerage.
Each of the parties hereto represents that it has had no dealings in connection with this transaction with any finder or broker who will
demand payment of any fee or commission from the other party. The Company on the one hand, and the Investor, on the other hand, agree
to indemnify the other against and hold the other harmless from any and all liabilities to any person claiming brokerage commissions or
finder’s fees on account of services purported to have been rendered on behalf of the indemnifying party in connection with this
Agreement or the transactions contemplated hereby.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    31 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Standby Equity Purchase Agreement to be executed by the undersigned, thereunto duly authorized, as
of the date first set forth above.

 

	
     
	COMPANY:
	 	Rubicon Technologies, Inc.
	 	 	 	 
	 	By:	/s/ Jevan Anderson
	 	Name: 	Jevan Anderson
	 	Title:	CFO
	 	 	 	 
	 	INVESTOR:
	 	YA II PN, Ltd.
	 	 	 	 
	 	By: 	Yorkville Advisors Global, LP
	 	Its: 	Investment Manager
	 	 	 	 
	 	 	By: 	Yorkville Advisors Global II, LLC
	 	 	Its: 	General Partner
	 	 	 	 
	 	By: 	/s/ Matt Beckman
	 	Name: 	Matt Beckman
	 	Title: 	Member

 

    32Exhibit 10.1

 

SEPARATION
AND GENERAL RELEASE AGREEMENT

 

This
Separation and General Release Agreement (the “Agreement”) is entered into by and between IDW Media Holdings, Inc. (the “Company”)
and Ezra Y. Rosensaft (“Employee”) (individually, each a “Party” and collectively, the “Parties”),
and the Parties agree to the terms and conditions set forth below:

 

1.
Employee’s employment with the Company terminated effective as of 11:59 p.m. (EDT) on August 28, 2022 (the “Separation Date”).
Following the Separation Date, other than Employee’s health insurance coverage, which shall continue through August 31, 2022, Employee
shall not be eligible to participate in, or be covered by, any employee benefit plan or program offered by or through the Company and
Employee shall not receive any benefits or payments from the Company except as specifically set forth in this Agreement. Regardless of
whether Employee signs this Agreement, Employee will be provided notice of Employee’s rights to continue Employee’s participation
in the Company’s group medical plan pursuant to the terms and conditions of the Consolidated Omnibus Budget Reconciliation Act,
or comparable state law, as applicable (“COBRA”).

 

2.
Obligations of the Company.

 

a.
The Company shall pay to Employee the total amount of Six Hundred Forty-Five Thousand Seven Hundred Eighty-Five Dollars ($645,785) (the
“Separation Pay”) (aggregate payments of $322,892.50 during each 12-month period), which will be paid to Employee less applicable
taxes and withholdings in fifty-two (52) substantially equal bi-weekly installments in accordance with the Company’s regular payroll
schedule beginning no later than the second payroll date following the Effective Date of this Agreement (as defined in Section 6.h. below).
The payments shall be made to Employee via direct deposit to the account to which Employee’s last payroll payment was made unless
he designates another account in writing; and

 

b.
Subject to Employee’s timely election of continuation coverage under COBRA and the eligibility requirements and other terms
and conditions of such insurance coverage, the Company shall, upon submission by Employee to the Company of appropriate
documentation substantiating payment by Employee to the Company’s COBRA vendor of the applicable COBRA coverage premium,
reimburse Employee for the portion of the premium costs for such coverage during the COBRA Reimbursement Period (as defined below)
that the Company would pay if Employee remained employed by the Company, at the same level of coverage that was in effect as of the
Separation Date (“COBRA Reimbursement”). Documentation substantiating payment to the COBRA vendor shall be submitted by
Employee to the Company within thirty (30) days of such payment and the Company shall make reimbursement to Employee within thirty
(30) days of receipt of such documentation. The “COBRA Reimbursement Period” shall begin on September 1, 2022 and end
upon the earliest of: (A) February 28, 2023; (B) the date Employee is no longer eligible to receive COBRA coverage; and (C) the date
on which Employee otherwise becomes eligible to receive medical insurance coverage from another employer. Employee agrees to notify
the Company within five (5) calendar days of becoming eligible to receive medical insurance coverage from another employer. Employee
agrees that if Employee does not timely elect COBRA coverage with the Company’s COBRA vendor or does not timely submit COBRA
premium payments to the COBRA vendor on an ongoing monthly basis, Employee will have voluntarily waived his entitlement to receive
COBRA Reimbursement hereunder. Following the expiration of the COBRA Reimbursement Period, Employee may elect to continue COBRA
coverage for the remainder of the COBRA eligibility period as defined by law, if any, at Employee’s own expense. In no event
will the Company be obligated to pay any portion of Employee’s COBRA coverage premiums for a period beyond the COBRA
Reimbursement Period Employee acknowledges and agrees that the foregoing constitutes good and sufficient consideration for
this Agreement, including the release contained herein.

 

    

     

    

 

3.
Obligations of Employee.

 

a.
Employee, on behalf of Employee, Employee’s heirs, executors, administrators, successors, and assigns and all persons who may have
a cause of action through Employee (collectively, “Releasors”), to the maximum extent permitted by law, completely and forever
releases the Company and its past, present and future direct and indirect parent companies, controlling or majority stockholders, partners,
divisions, subsidiaries, affiliates, trustees, corporations under common control or ownership, business partners, and each of their current
and former officers, directors, shareholders, members, attorneys, insurers, agents, and employees, and each of their predecessors, successors,
and assigns, and all related persons, individually and in their official capacities, and their employee benefit plans and programs and
their administrators and fiduciaries (collectively, “Releasees”), from any and all claims, demands, actions, or liabilities,
known or unknown, including without limitation any claims arising out of Employee’s former employment with the Company and/or Employee’s
separation therefrom, including, but not limited to, any and all claims under Title VII of the Civil Rights Act of 1964, as amended;
42 U.S.C. § 1981; the Age Discrimination in Employment Act (“ADEA”), as amended, and the Older Workers Benefit
Protection Act; the Employee Retirement Income Security Act of 1974, as amended; the Family and Medical Leave Act, as amended; the Americans
with Disabilities Act of 1990, as amended; the Rehabilitation Act of 1973, as amended; the Equal Pay Act, as amended; the Occupational
Safety and Health Act; the Consolidated Omnibus Budget Reconciliation Act; the Genetic Information Non-Discrimination Act of 2008; the
Pregnancy Discrimination Act of 1978; the Immigration Reform and Control Act; the Workers Adjustment and Retraining Notification Act;
the Fair Credit Reporting Act; the New Jersey Law Against Discrimination (N.J.S.A. 10:5-1 et seq.); the New Jersey Conscientious Employee
Protection Act (N.J.S.A. 34:19-1 et seq.); the New Jersey Wage Payment Law; the New Jersey Wage and Hour Law; the New Jersey Equal Pay
Act; the New Jersey Earned Sick Leave Law; the New Jersey Family Leave Act; retaliation claims under the New Jersey Workers’ Compensation
Law; any other applicable laws, statutes, local ordinances, rules, and regulations (including without limitation any New Jersey, New
York, and New York City laws, statutes, ordinances, rules, and regulations); and all laws that govern discrimination, including without
limitation discrimination based on religion, color, race, sex, pregnancy, sexual harassment, national origin, marital status, genetic
information, age, retaliation, handicap, and/or disability, all as amended; and any other statutory, common law, or public policy claim,
including without limitation any tort claim (including without limitation any claim for misrepresentation or fraud, assault, battery,
intentional infliction of emotional distress, tortious interference with employment, defamation, invasion of privacy, negligence, or
negligent hiring, retention, or supervision), any contract claim, and any employment law claim (including without limitation any claim
concerning recruitment, hiring, termination, retaliation, severance pay, stock options, whistleblowing, compensation, sick leave, holiday
pay, vacation pay, fringe benefits, discrimination and/or harassment); whether federal, state, or local; whether in law or in equity;
whether of any type whatsoever arising from the beginning of the world to the date of Employee’s execution of this Agreement. Employee
expressly intends this release to reach to the maximum extent permitted by law. The above list of statutes is meant to be illustrative,
not exhaustive. However, nothing in this Agreement shall be construed to prevent Employee from enforcing Employee’s rights under
this Agreement, filing a claim to collect any benefits available to Employee under the applicable state Unemployment Compensation or
Worker’s Compensation laws, asserting claims for accrued, vested benefits under any employee benefit plans in accordance with the
terms of such plans and applicable law, or pursuing claims which by law cannot be waived by signing this Agreement. If any claim is not
subject to release, to the extent permitted by law, Releasors waive any right or ability to be a class or collective action representative
or to otherwise participate in any putative or certified class, collective, or multi-party action or proceeding based on such a claim
in which Releasees are a party.

 

    Page 2

     

    

 

b.
Employee agrees and acknowledges that the consideration provided for in this Agreement exceeds any payments, benefit, or thing of value
to which Employee might otherwise be entitled to from the Company under any contract, policy, plan, procedure, or otherwise.

 

c.
Employee agrees, to the maximum extent permitted by law, not to disclose any information regarding the underlying facts leading up to
this Agreement, except to his spouse/significant other, tax advisor(s)/accountant(s), and/or attorney(s). Employee further agrees, to
the maximum extent permitted by law, not to make, or induce or cause any other person or entity to make, negative statements or communications
disparaging the Company or its subsidiaries, affiliates, officers, directors, managers, shareholders, members, agents, business, practices,
services or products. Responding to legal process, required governmental testimony or filings, or administrative proceedings (including,
without limitation, depositions in connection with such proceedings), or making disclosures that cannot be prohibited pursuant to applicable
federal, state, or local law will not violate the obligations of this paragraph.

 

d.
Employee agrees that he will not use or disclose or permit the disclosure of any Confidential Information (as defined below) to any third
party, except that making a disclosure pursuant to the following paragraph, responding to legal process, required governmental testimony
or filings, or administrative proceedings (including without limitation depositions in connection with such proceedings), or making disclosures
that cannot be prohibited pursuant to applicable federal, state, or local law will not violate the obligations of this paragraph. “Confidential
Information” means technical and proprietary information about the Company and its corporate subsidiaries and affiliates and their
subsidiaries, affiliates, business partners, customers, products, and services that was learned by Employee during his employment with
the Company, whether or not such information is marked as confidential, including without limitation any and all (i) inventions, trade
secrets (as defined by the Defend Trade Secrets Act, 18 U.S.C. § 1839(3) and any applicable state law), computer programs, computer
source and access codes, and other technology, (ii) records and databases, (iii) licenses and other agreements with third parties, (iv)
product and service costs, prices, profits, and sales, (v) marketing and business strategies, plans, forecasts, budgets, projections,
analyses, and various other financial information, (vi) existing or prospective client, customer, investor, vendor, and supplier information,
(vii) information received from and/or regarding third parties where the Company agreed to hold such information in confidence, and (viii)
analyses and forecasts, patents, and copyrights, in each case where such information is not generally known or readily available to the
public (unless via a breach of Employee’s obligation to the Company). Confidential Information excludes any information that became
known to Employee outside the scope of his Employment from a third party not under any obligations of confidentiality to the Company.
Confidential Information includes information in any form or media, including without limitation documentary, written, oral, magnetic,
electronically transmitted, or computer generated. Employee acknowledges that Confidential Information is specialized, unique in nature
and of great value to the Company, and that such information gives the Company a competitive advantage.

 

Notice
of Immunity: Employee acknowledges that via this paragraph the Company is providing him with written notice that the Defend Trade Secrets
Act, 18 U.S.C. § 1833(b), provides that (i) an individual shall not be held criminally or civilly liable under any federal or state
trade secret law for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official, either
directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law, or
is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal, and (ii) an individual
who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the employer’s trade
secret to the individual’s attorney and use such trade secret information in the court proceeding if the individual files any document
containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

 

    Page 3

     

    

 

e.
Employee agrees that for a period of twelve (12) months following the Effective Date of this Agreement, Employee shall not, directly
or indirectly, on Employee’s own behalf or on behalf of any other person or entity other than Company, (i) with respect to any
third party that is a vendor, consultant, client, or customer of Company or its corporate affiliates or subsidiaries, where Employee
had material contact with such third party as a representative of Company, (A) encourage or influence or attempt to influence such third
party to reduce such third party’s business with Company or its corporate affiliates or subsidiaries or (B) divert such third party’s
business to any competitor of Company or its corporate affiliates or subsidiaries or use the relationship with such third party to the
detriment of the Company or its corporate affiliates or subsidiaries; or (ii) solicit or recruit, or attempt to solicit or recruit, any
individual who is employed or engaged as an independent contractor by Company or its corporate affiliates or subsidiaries for the purpose
of being employed by or engaged as an independent contractor by a competitor of Company or its corporate affiliates or subsidiaries.

 

f.
Employee acknowledges that he understands that notwithstanding the foregoing, nothing in this Agreement precludes Employee from filing
a charge with the Equal Employment Opportunity Commission (“EEOC”), the National Labor Relations Board (“NLRB”),
or any comparable federal, state, or local governmental agency or testifying, assisting, or participating in any investigation, hearing
or proceeding conducted by such agency. However, to the maximum extent permitted by law, Employee, for Employee and the Releasors, waives
any right to monetary or other recovery should any claim be pursued by any person, organization, or other entity against Releasees on
their behalf arising out of or related to Employee’s employment with or separation from the Company.

 

Employee
further acknowledges that Employee understands that nothing in this Agreement or any other agreement with the Company limits Employee’s
ability to communicate with the Securities Exchange Commission or otherwise participate in any investigation or proceeding that may be
conducted by the Securities Exchange Commission, including providing documents or other information, without notice to the Company, nor
limits Employee’s right to receive an award for information provided to the Securities Exchange Commission.

 

g.
Employee agrees to furnish such information and assistance to the Company as may be reasonably requested by the Company in connection
with any issues or matters of which Employee had knowledge during Employee’s employment with the Company, including without limitation,
taking all action necessary or reasonably requested in order to ensure an orderly transition of Employee’s prior duties to other
employees of the Company. Further, Employee agrees that Employee will assist and cooperate with the Company in connection with the defense
or prosecution of any claim that may be made against or by the Company, or in connection with any ongoing or future investigation or
dispute or claim of any kind involving the Company, including any proceeding before any arbitral, administrative, judicial, legislative,
or other body or agency, including testifying in any proceeding to the extent such claims, investigations, or proceedings relate to services
performed or required to be performed by Employee, pertinent knowledge possessed by Employee, or any act or omission by Employee. Employee
further agrees to perform all acts and execute and deliver any documents that may be reasonably necessary to carry out the provisions
of this paragraph.

 

    Page 4

     

    

 

h.
Employee warrants that neither Employee, nor anyone acting on Employee’s behalf, has filed any civil action, suit, arbitration,
administrative charge, or legal proceeding, whether in court, in an arbitral forum, or with an administrative agency, against any of
the Releasees. Employee warrants that Employee has not made any claim or allegations to the Company related to discrimination, retaliation,
or harassment. Employee acknowledges that Employee has received all wages, bonuses, and compensation to which Employee was entitled by
virtue of Employee’s former employment with the Company, as well as any and all paid time off, leave or other benefits to which
Employee may have been entitled by virtue of Employee’s former employment with the Company. Employee affirms Employee has no known
workplace injuries or occupational diseases. Employee further warrants that Employee has not been retaliated against for reporting any
allegations of wrongdoing by the Company, including any allegations of corporate fraud.

 

i.
Employee represents and warrants that as of the Company’s receipt of this Agreement fully executed by Employee, Employee has returned
to the Company all Company confidential and proprietary information, technical data, trade secrets, and/or know-how embodied in any medium
that was in his possession and has returned to the Company all other property belonging to the Company, except for the Company-issued
laptop computer that was provided to Employee for use during Employee’s employment (the “Laptop”), which the Company
permits Employee to retain as Employee’s own property after deletion of all Company confidential information and Company licensed
software . Employee further represents and warrants that as of the Company’s receipt of this Agreement fully executed by Employee,
Employee has permanently deleted all information regarding the Company from the Laptop.

 

j.
Any claim or counterclaim by the Company to enforce this Agreement shall not be deemed retaliatory.

 

4.
No Admission of Liability.

 

The
parties acknowledge that this Agreement is not an admission of liability or wrongdoing by anyone, and all parties deny any wrongdoing
or violation of law.

 

5.
Consultation with an Attorney.

 

Employee
expressly acknowledges that Employee has been advised to consult with an attorney before signing this Agreement.

 

6.
General Terms.

 

a.
The parties affirm that the terms stated in this Agreement are the only consideration for them to sign this Agreement, and no other promise
or agreement of any kind has been made to or with them by any person or entity whomsoever to cause them to execute this Agreement, and
that they fully understand the meaning and intent of this Agreement, including but not limited to its final and binding effect. Except
for any confidentiality, assignment of inventions, and/or non-solicitation obligations that Employee may have to the Company that are,
by their terms, intended to survive termination of employment, which shall remain in full force and effect, this Agreement contains the
entire agreement between the parties and replaces any and all prior contracts, agreements, or understandings between the parties arising
out of or relating to the employment of Employee and the separation of Employee’s employment. This Agreement may only be changed
in a writing signed by both the Company and Employee.

 

    Page 5

     

    

 

b.
This Agreement shall be construed, enforced and interpreted in accordance with the laws of the State of New Jersey, without regard to
New Jersey’s conflict of laws principles, and the exclusive venue for any action to enforce or construe the Agreement shall be
in federal or state court in Essex County, New Jersey. It is agreed that each party irrevocably consents to the exercise of personal
jurisdiction over such party by such courts, agrees that venue shall be proper in such courts, and irrevocably waives and releases any
and all defenses based on lack of personal jurisdiction, improper venue or forum non conveniens.

 

c.
Employee acknowledges and agrees that the Company would be irreparably injured by a breach of Section 3(c), 3(d), or 3(e) of this Agreement
by Employee and that monetary remedies would be inadequate to protect against any actual or threatened breach of such Sections under
this Agreement. Without prejudice to any other rights and remedies otherwise available to the Company, Employee agrees to the granting
of equitable relief, including injunctive relief and specific performance, in favor of the Company without proof of actual damages or
posting any bonds to remedy or prevent any such breach.

 

d.
Internal Revenue Code Section 409A.  The intent of the parties is that payments and benefits under this Agreement (i) either comply
with, or are exempt from, Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated
thereunder (“Section 409A”), and (ii) are exempt from the requirement under Treasury Regulation Section 1.409A-3(i)(2)(i),
relating to a six-month delay in payment of deferred compensation to a “specified employee” (as defined in Treasury Regulation
Section 1.409A-1(i)) because Employee is not a “specified employee” and/or the payments hereunder are exempt from Section
409A. Accordingly, to the maximum extent permitted, this Agreement shall be construed, interpreted and administered in a manner consistent
with the requirements for avoiding taxes or penalties under Section 409A.  Each amount to be paid or benefit to be provided under
this Agreement shall be construed as a separate and distinct payment for purposes of Section 409A.  The Company makes no representation
that any or all of the payments described in this Agreement will be exempt from or comply with Section 409A and makes no undertaking
to preclude Section 409A from applying to any such payment. Employee understands and agrees that Employee shall be solely responsible
for the payment of any taxes, penalties, interest or other expenses incurred by Employee on account of non-compliance with Section 409A.

 

e.
The invalidity or unenforceability of any provision herein shall not affect the validity or enforceability of any other provision herein.
If a court of competent jurisdiction determines that any provision of this Agreement is invalid, illegal, or unenforceable (whether in
whole or in part), such provision shall be deemed modified to the extent, but only to the extent, necessary so that it is valid, legal,
and enforceable, and the other provisions of this Agreement shall continue in full force and effect; provided, if a court of competent
jurisdiction determines that any provision of this Agreement cannot be made enforceable, it shall be severed without affecting the validity
or enforceability of any other provision of this Agreement, and further provided that if such provision is a release or covenant set
forth in paragraph 3 of this Agreement, Employee agrees to execute a release or covenant of comparable scope that is legal and enforceable.
Without limiting the generality of the foregoing, if any one or more of the provisions contained in this Agreement is determined by a
court of competent jurisdiction to be excessively broad as to duration, geographical area, scope, activity or subject, or is unreasonable
or unenforceable under applicable law, such provisions will be construed by limiting, reducing, modifying, or amending them so as to
be enforceable to the maximum extent permitted by such applicable law. If this Agreement is held unenforceable to any extent in any jurisdiction,
such holding will not impair the enforceability of the Agreement in any other jurisdiction.

 

    Page 6

     

    

 

f.
This Agreement is binding upon, and shall inure to the benefit of, the parties and their respective heirs, executors, administrators,
successors, and assigns.

 

g.
This Agreement may be executed in counterparts, and if so executed each such counterpart shall have the force and effect of an original.
The parties represent and warrant that they are authorized and entitled to sign this Agreement and that no other person or entity has
any interest in the matters released in this Agreement and that the parties own and have not sold, pledged, assigned or transferred to
any person or entity all or any portion of the matters or claims released in this Agreement and that the parties will indemnify and hold
harmless each other from any such claim that may be asserted against the other by any other person or entity. The person signing this
agreement on behalf of the Company is authorized to do so.

 

h.
TO RECEIVE THE PROMISES AND BENEFITS UNDER THIS AGREEMENT, EMPLOYEE MUST ACCEPT THIS AGREEMENT BY SIGNING AND RETURNING THIS AGREEMENT
TO THE COMPANY VIA EMAIL TO BROOKE FEINSTEIN AT brooke@idwmh.com AFTER AUGUST 28, 2022 AND ON OR BEFORE SEPTEMBER 19, 2022 (AND NOT THEREAFTER
REVOKE HIS ACCEPTANCE). EMPLOYEE HEREBY ACKNOWLEDGES THAT HE HAS BEEN GIVEN AT LEAST TWENTY-ONE (21) CALENDAR DAYS TO CONSIDER THIS AGREEMENT.
EMPLOYEE ACKNOWLEDGES THAT HE UNDERSTANDS THAT HE MAY VOLUNTARILY WAIVE SOME OR ALL OF THE TWENTY-ONE (21) DAY PERIOD. EMPLOYEE FURTHER
ACKNOWLEDGES THAT, IN THE EVENT THAT HE EXECUTES AND RETURNS THIS AGREEMENT PRIOR TO THE END OF THE TWENTY-ONE (21) DAY PERIOD, EMPLOYEE’S
DECISION TO DO SO WILL NOT HAVE BEEN INDUCED BY A THREAT TO WITHDRAW OR ALTER THE OFFER PRIOR TO THE EXPIRATION OF THE TWENTY-ONE (21)
DAY PERIOD. EMPLOYEE ACKNOWLEDGES THAT HE HAS BEEN ADVISED TO CONSULT WITH AN ATTORNEY PRIOR TO SIGNING THIS AGREEMENT. EMPLOYEE ACKNOWLEDGES
THAT EMPLOYEE’S SIGNING THIS AGREEMENT IS COMPLETELY KNOWING AND VOLUNTARY.

 

EMPLOYEE
MAY REVOKE THIS AGREEMENT FOR A PERIOD OF SEVEN (7) CALENDAR DAYS FOLLOWING THE DAY EMPLOYEE SIGNS THIS AGREEMENT BY DELIVERING A WRITTEN
STATEMENT OF REVOCATION TO THE COMPANY VIA EMAIL TO BROOKE FEINSTEIN AT brooke@idwmh.com. THIS AGREEMENT SHALL NOT BE EFFECTIVE UNTIL
THE EIGHTH (8TH) DAY FOLLOWING EMPLOYEE’S EXECUTION THEREOF (THE “EFFECTIVE DATE”). 

 

IN
THE EVENT EMPLOYEE SIGNS THIS AGREEMENT PRIOR TO AUGUST 29, 2022, IT IS DATED OR RECEIVED BY THE COMPANY AFTER SEPTEMBER 19, 2022, OR
EMPLOYEE REVOKES THIS AGREEMENT ON OR BEFORE THE EXPIRATION OF THE SEVEN (7) DAY REVOCATION PERIOD, THE COMPANY SHALL NOT BE OBLIGATED
TO PROVIDE ANY OF THE CONSIDERATION SET FORTH IN THIS AGREEMENT AND THIS AGREEMENT SHALL BE NULL AND VOID AND OF NO FORCE OR EFFECT.

 

EMPLOYEE
ACKNOWLEDGES THAT EMPLOYEE FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS AGREEMENT.

 

The
Parties knowingly and voluntarily sign this Agreement as of the date(s) set forth below:

 

	 	IDW Media Holdings, Inc.
	 	 	 
	 	By:	/s/ Brooke Feinstein

 

	By:	/s/ Ezra Y. Rosensaft	 	Print Name:	Brooke Feinstein
	 	Ezra Y. Rosensaft	 	Print Title: 	Chief Financial Officer

 

	Date:	29 August 2022	 	Date:	08/29/2022

 

 

Page 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]